Form 4: Moelis & Co. Executive Navid Mahmoodzadegan Reports Transaction in Incentive RSUs
SEC Form 4 Filing
Navid Mahmoodzadegan, Co-President and MD of Moelis & Co, reports a transaction involving Incentive Restricted Stock Units (RSUs) on March 28, 2024.
Summary
- Navid Mahmoodzadegan, a Co-President and Managing Director at Moelis & Co, filed a Form 4 with the SEC.
- The filing reports a transaction involving 2019 Incentive Restricted Stock Units (RSUs) on March 28, 2024.
- 579.99 Incentive RSUs were acquired as dividend equivalents.
- These RSUs are related to unvested underlying Incentive RSUs issued on February 13, 2020, and will vest concurrently.
- The reporting person's holdings following the reported transaction include 55,456.26 derivative securities.
- Each RSU represents the right to receive either a share of Class A common stock or an equivalent amount of cash, at Moelis & Company's discretion.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an executive's transaction in company stock, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and their potential impact on the stock's performance.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 02/13/2020 | Date of issuance of the underlying Incentive RSUs. |
| 03/28/2024 | Date of the reported transaction involving Incentive RSUs. |
| 04/02/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.